190 related articles for article (PubMed ID: 27910913)
1. Loss of EGFR-ASAP1 signaling in metastatic and unresectable hepatoblastoma.
Ranganathan S; Ningappa M; Ashokkumar C; Higgs BW; Min J; Sun Q; Schmitt L; Subramaniam S; Hakonarson H; Sindhi R
Sci Rep; 2016 Dec; 6():38347. PubMed ID: 27910913
[TBL] [Abstract][Full Text] [Related]
2. General paucity of genomic alteration and low tumor mutation burden in refractory and metastatic hepatoblastoma: comprehensive genomic profiling study.
Lee H; El Jabbour T; Ainechi S; Gay LM; Elvin JA; Vergilio JA; Suh J; Ramkissoon SH; Ali SM; Schrock A; Fabrizio D; Frampton G; Nazeer T; Miller VA; Stephens PJ; Ross JS
Hum Pathol; 2017 Dec; 70():84-91. PubMed ID: 29079173
[TBL] [Abstract][Full Text] [Related]
3. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells.
Bae JA; Yoon S; Park SY; Lee JH; Hwang JE; Kim H; Seo YW; Cha YJ; Hong SP; Kim H; Chung IJ; Kim KK
Clin Cancer Res; 2014 Aug; 20(15):4115-28. PubMed ID: 24893630
[TBL] [Abstract][Full Text] [Related]
4. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors.
López-Terrada D; Gunaratne PH; Adesina AM; Pulliam J; Hoang DM; Nguyen Y; Mistretta TA; Margolin J; Finegold MJ
Hum Pathol; 2009 Jun; 40(6):783-94. PubMed ID: 19200579
[TBL] [Abstract][Full Text] [Related]
5. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
6. Changing treatment and outcome of children with hepatoblastoma: analysis of a single center experience over the last 20 years.
Ismail H; Broniszczak D; Kaliciński P; Dembowska-Bagińska B; Perek D; Teisseyre J; Kluge P; Kościesza A; Lembas A; Markiewicz M
J Pediatr Surg; 2012 Jul; 47(7):1331-9. PubMed ID: 22813792
[TBL] [Abstract][Full Text] [Related]
7. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence.
Reyes JD; Carr B; Dvorchik I; Kocoshis S; Jaffe R; Gerber D; Mazariegos GV; Bueno J; Selby R
J Pediatr; 2000 Jun; 136(6):795-804. PubMed ID: 10839879
[TBL] [Abstract][Full Text] [Related]
8. Effect of Liver Transplant on Long-term Disease-Free Survival in Children With Hepatoblastoma and Hepatocellular Cancer.
Pham TA; Gallo AM; Concepcion W; Esquivel CO; Bonham CA
JAMA Surg; 2015 Dec; 150(12):1150-8. PubMed ID: 26308249
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling as a useful therapeutic target in hepatoblastoma.
Sha YL; Liu S; Yan WW; Dong B
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31511432
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and prognostic impact of beta-catenin alterations in pediatric liver tumors.
Yamaoka H; Ohtsu K; Sueda T; Yokoyama T; Hiyama E
Oncol Rep; 2006 Mar; 15(3):551-6. PubMed ID: 16465411
[TBL] [Abstract][Full Text] [Related]
11. Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability.
Ueda Y; Hiyama E; Kamimatsuse A; Kamei N; Ogura K; Sueda T
J Pediatr Surg; 2011 Dec; 46(12):2221-7. PubMed ID: 22152854
[TBL] [Abstract][Full Text] [Related]
12. Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.
Héry G; Franchi-Abella S; Habes D; Brugières L; Martelli H; Fabre M; Pariente D; Gauthier F; Jacquemin E; Branchereau S
Pediatr Blood Cancer; 2011 Dec; 57(7):1270-5. PubMed ID: 21910210
[TBL] [Abstract][Full Text] [Related]
13. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
[TBL] [Abstract][Full Text] [Related]
14. Novel Advances in Understanding of Molecular Pathogenesis of Hepatoblastoma: A Wnt/β-Catenin Perspective.
Bell D; Ranganathan S; Tao J; Monga SP
Gene Expr; 2017 Feb; 17(2):141-154. PubMed ID: 27938502
[TBL] [Abstract][Full Text] [Related]
15. GREB1 induced by Wnt signaling promotes development of hepatoblastoma by suppressing TGFβ signaling.
Matsumoto S; Yamamichi T; Shinzawa K; Kasahara Y; Nojima S; Kodama T; Obika S; Takehara T; Morii E; Okuyama H; Kikuchi A
Nat Commun; 2019 Aug; 10(1):3882. PubMed ID: 31462641
[TBL] [Abstract][Full Text] [Related]
16. Cellular origin and molecular mechanisms of lung metastases in patients with aggressive hepatoblastoma.
Gulati R; Lutz M; Hanlon M; Cast A; Karns R; Geller J; Bondoc A; Tiao G; Timchenko L; Timchenko NA
Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38285876
[TBL] [Abstract][Full Text] [Related]
17. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
Häberle B; Bode U; von Schweinitz D
Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
[TBL] [Abstract][Full Text] [Related]
18. Analysis of national and single-center incidence and survival after liver transplantation for hepatoblastoma: new trends and future opportunities.
Cruz RJ; Ranganathan S; Mazariegos G; Soltys K; Nayyar N; Sun Q; Bond G; Shaw PH; Haberman K; Krishnamurti L; Marsh JW; Humar A; Sindhi R
Surgery; 2013 Feb; 153(2):150-9. PubMed ID: 23331862
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of human hepatoblastoma using archived formalin-fixed and paraffin-embedded tissues.
Shin E; Lee KB; Park SY; Kim SH; Ryu HS; Park YN; Yu E; Jang JJ
Virchows Arch; 2011 Apr; 458(4):453-65. PubMed ID: 21369802
[TBL] [Abstract][Full Text] [Related]
20. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
